Gray B, Barnes N
Department of Thoracic Medicine, King's College School of Medicine & Dentistry, London, U.K.
Adv Exp Med Biol. 1987;220:71-3. doi: 10.1007/978-1-4613-1927-6_12.
The administration of histamine and leukotriene D4 (LTD4) by nebulised aerosol in logarithmically increasing doses to normal subjects resulted in significant bronchoconstriction. Transcutaneous oxygen tension (tcPO2) was monitored during and after the bronchial challenge tests. Following histamine challenge there was significant hypoxaemia in all subjects (mean fall in tcPO2, 20 mmHg). However, following LTD4 administration, there was a small and insignificant fall in tcPO2. Transcutaneous carbon dioxide tension (tcPCO2) was also monitored throughout bronchial challenge, but showed no significant change. We suggest that the hypoxaemia following histamine challenge was due to increased ventilation/perfusion (V/Q) mismatching in the lung induced by histamine deposition.
对正常受试者以对数递增剂量通过雾化气溶胶给予组胺和白三烯D4(LTD4)会导致显著的支气管收缩。在支气管激发试验期间及之后监测经皮氧分压(tcPO2)。组胺激发后,所有受试者均出现显著低氧血症(tcPO2平均下降20 mmHg)。然而,给予LTD4后,tcPO2有小幅下降但无显著意义。在整个支气管激发过程中也监测了经皮二氧化碳分压(tcPCO2),但未显示出显著变化。我们认为,组胺激发后的低氧血症是由于组胺沉积诱导肺内通气/灌注(V/Q)不匹配增加所致。